Ko Kwan Soo, Suh Ji Yoeun, Kwon Ki Tae, Jung Sook-In, Park Kyong-Hwa, Kang Cheol In, Chung Doo Ryeon, Peck Kyong Ran, Song Jae-Hoon
Department of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Suwon, Korea.
J Antimicrob Chemother. 2007 Nov;60(5):1163-7. doi: 10.1093/jac/dkm305. Epub 2007 Aug 29.
To investigate antimicrobial resistance in clinical isolates of Acinetobacter spp. from two Korean hospitals.
Two hundred and sixty-five isolates of Acinetobacter spp. from two Korean hospitals were collected and were identified to species level using partial rpoB gene sequences. Antimicrobial susceptibility testing was performed using a broth microdilution method.
rpoB gene sequences indicated that 214 isolates (80.8%) were Acinetobacter baumannii, and allowed these to be classified into three subgroups (I, II and III); 142 isolates (53.6%) belonged to subgroup I, 54 (20.4%) to subgroup II and 18 (6.8%) to subgroup III. Forty-eight isolates (18.1%) and 74 isolates (27.9%) were resistant to polymyxin B and colistin, respectively. However, antimicrobial resistance rates varied markedly between subgroups. While A. baumannii subgroup I showed low resistance rates to polymyxin B and colistin (2.1% and 7.0%, respectively), subgroups II and III showed high resistance rates to these antibiotics (38.9% and 64.8% in subgroup II and 72.2% and 88.9%, in subgroup III, respectively). Multidrug resistance was also significantly more frequent in subgroup I (45.1%) than in subgroups II and III (13.0% and 16.7%, respectively).
Our data indicate that subgroup identification of A. baumannii may aid selection of appropriate antimicrobial agents for the treatment of Acinetobacter infections.
调查韩国两家医院不动杆菌属临床分离株的抗菌药物耐药性。
收集韩国两家医院的265株不动杆菌属分离株,使用部分rpoB基因序列将其鉴定到种水平。采用肉汤微量稀释法进行抗菌药物敏感性试验。
rpoB基因序列表明,214株分离株(80.8%)为鲍曼不动杆菌,并可分为三个亚组(I、II和III);142株分离株(53.6%)属于亚组I,54株(20.4%)属于亚组II,18株(6.8%)属于亚组III。48株分离株(18.1%)和74株分离株(27.9%)分别对多粘菌素B和粘菌素耐药。然而,不同亚组之间的抗菌药物耐药率差异显著。鲍曼不动杆菌亚组I对多粘菌素B和粘菌素的耐药率较低(分别为2.1%和7.0%),而亚组II和III对这些抗生素的耐药率较高(亚组II分别为38.9%和64.8%,亚组III分别为72.2%和88.9%)。亚组I的多重耐药也明显比亚组II和III更常见(分别为45.1%、13.0%和16.7%)。
我们的数据表明,鲍曼不动杆菌的亚组鉴定可能有助于选择合适的抗菌药物来治疗不动杆菌感染。